deltatrials
Terminated PHASE2/PHASE3 INTERVENTIONAL 1-arm NCT02854670

A Study of the Effects of Topical Capsaicin in the Treatment of Provoked Vestibulodynia (CAPSIVU)

Sponsor: Centre Hospitalier Universitaire de Besancon

Conditions Vestibulodynia
Interventions Capsaicin patch
Updated 7 times since 2017 Last updated: Nov 9, 2022 Started: Jan 20, 2016 Primary completion: Feb 3, 2021 Completion: Feb 3, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Recruitment difficulties

Other terminated trials from Centre Hospitalier Universitaire de Besancon

See all terminations from Centre Hospitalier Universitaire de Besancon

Other Vestibulodynia trials with similar outcome

Browse all Vestibulodynia trials

Listed as NCT02854670, this PHASE2/PHASE3 trial focuses on Vestibulodynia and remains terminated or withdrawn. Sponsored by Centre Hospitalier Universitaire de Besancon, it has been updated 7 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotRecruiting~Jun 2018 – ~Sep 2019 · 15 months · monthly snapshotRecruiting~Sep 2019 – ~Jan 2021 · 16 months · monthly snapshotUnknown Status~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotUnknown Status~Dec 2022 – ~Jul 2024 · 19 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2/PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2/PHASE3

    Phase: PHASE2_PHASE3 → PHASE2/PHASE3

  3. Dec 2022 — Jul 2024 [monthly]

    Terminated PHASE2_PHASE3

    Status: Unknown Status → Terminated

  4. Jan 2021 — Dec 2022 [monthly]

    Unknown Status PHASE2_PHASE3

  5. Sep 2019 — Jan 2021 [monthly]

    Unknown Status PHASE2_PHASE3

    Status: Recruiting → Unknown Status

▶ Show 2 earlier versions

  1. Jun 2018 — Sep 2019 [monthly]

    Recruiting PHASE2_PHASE3

  2. Jan 2017 — Jun 2018 [monthly]

    Recruiting PHASE2_PHASE3

    First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Centre Hospitalier Universitaire de Besancon
Data source: Centre Hospitalier Universitaire de Besancon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations